The Society for Immunotherapy of Cancer (SITC) hosted the "Concurrent Session 104: Clinical Trials: New Agents" during the SITC 2017 Annual Meeting on November 10, 2017. Available here are the presentation slides and video from the session.Program Organizers
Meeting: SITC 32 Annual Meeting; Concurrent Session 104: Clinical Trials: New Agents; Presenter: James L. Gulley, MD, PhD, FACP – National Cancer Institute; Date: November 10, 201700:17:07
Meeting: SITC 32 Annual Meeting; Concurrent Session 104: Clinical Trials: New Agents; Presenter: Kim Margolin, MD, FACP – City of Hope; Date: November 10, 201700:17:50
Meeting: SITC 32 Annual Meeting; Concurrent Session 104: Clinical Trials: New Agents; Presenter: Yung Jue Bang, PhD, MD – Seoul National University Hospital; Date: November 10, 201700:09:28
Meeting: SITC 32 Annual Meeting; Concurrent Session 104: Clinical Trials: New Agents; Presenter: David Hong, MD – University of Texas MD Anderson Cancer Center; Date: November 10, 201700:12:34
Meeting: SITC 32 Annual Meeting; Concurrent Session 104: Clinical Trials: New Agents; Presenter: Peter Ellmark, PhD – Alligator Bioscience; Date: November 10, 201700:14:24
Join
Renew
Member Directory
My Profile
Email Sign-up
Volunteer
Support SITC
Contact Us